Interim Segment Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 |
Dec. 31, 2016 |
Dec. 31, 2017 |
Dec. 31, 2016 |
Mar. 31, 2017 |
|||||||||||
Segment information | |||||||||||||||
Total revenue | $ 13,675 | $ 14,983 | $ 47,481 | $ 47,579 | |||||||||||
Total cost of revenue (1) | 7,599 | 8,929 | 27,363 | 30,593 | [1] | ||||||||||
Gross profit | $ 6,076 | $ 6,054 | $ 20,118 | $ 16,986 | [1] | ||||||||||
Gross margin | 44.40% | 40.40% | 42.40% | 35.70% | [1] | ||||||||||
Research and development | $ 1,542 | $ 2,414 | $ 6,023 | $ 10,018 | |||||||||||
Segment Profit Loss | 4,534 | 3,640 | 14,095 | 6,968 | |||||||||||
Operating expenses | |||||||||||||||
Sales and marketing | 1,950 | 1,943 | 6,278 | 8,220 | |||||||||||
General and administrative | 1,502 | 1,777 | 5,022 | 6,340 | |||||||||||
Intangible amortization | 1,047 | 1,212 | 3,142 | 3,613 | |||||||||||
Restructuring | 490 | 165 | 3,055 | $ 3,200 | |||||||||||
Impairment of Long-Lived Assets to be Disposed of | 0 | 0 | 0 | 1,181 | |||||||||||
Operating profit (loss) | 35 | (1,782) | (512) | (15,441) | |||||||||||
Other Nonoperating Income (Expense) | 79 | (15) | 799 | [2] | 76 | ||||||||||
Income tax benefit (expense) | 685 | [3] | (10) | 660 | [3] | (20) | |||||||||
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | 799 | (1,807) | 947 | (15,385) | |||||||||||
IBW [Member] | |||||||||||||||
Segment information | |||||||||||||||
Total revenue | 5,223 | 6,224 | 20,098 | 18,989 | |||||||||||
Total cost of revenue (1) | 2,754 | 3,713 | [1] | 10,965 | 13,251 | [1] | |||||||||
Gross profit | $ 2,469 | $ 2,511 | [1] | $ 9,133 | $ 5,738 | [1] | |||||||||
Gross margin | 47.30% | 40.30% | [1] | 45.40% | 30.20% | [1] | |||||||||
Research and development | $ 750 | $ 1,307 | $ 3,656 | $ 5,265 | |||||||||||
Segment Profit Loss | 1,719 | 1,204 | 5,477 | 473 | |||||||||||
ISMS [Member] | |||||||||||||||
Segment information | |||||||||||||||
Total revenue | 5,802 | 5,525 | 14,662 | 14,773 | |||||||||||
Total cost of revenue (1) | 2,642 | 2,730 | 7,157 | 7,552 | |||||||||||
Gross profit | $ 3,160 | $ 2,795 | $ 7,505 | $ 7,221 | |||||||||||
Gross margin | 54.50% | 50.60% | 51.20% | 48.90% | |||||||||||
Research and development | $ 547 | $ 805 | $ 1,635 | $ 3,336 | |||||||||||
Segment Profit Loss | 2,613 | 1,990 | 5,870 | 3,885 | |||||||||||
CNS [Member] | |||||||||||||||
Segment information | |||||||||||||||
Total revenue | 2,650 | 3,234 | 12,721 | 13,817 | |||||||||||
Total cost of revenue (1) | 2,203 | 2,486 | 9,241 | 9,790 | |||||||||||
Gross profit | $ 447 | $ 748 | $ 3,480 | $ 4,027 | |||||||||||
Gross margin | 16.90% | 23.10% | 27.40% | 29.10% | |||||||||||
Research and development | $ 245 | $ 302 | $ 732 | $ 1,417 | |||||||||||
Segment Profit Loss | $ 202 | $ 446 | $ 2,748 | $ 2,610 | |||||||||||
|